Latest Articles

Publication Date
Bindi Irwin misses another annual gala for late dad amid 'challenging' endometriosis battle - MSN

Bindi Irwin misses another annual gala for late dad amid 'challenging' endometriosis battle MSN

Published: May 23, 2026, 2:19 a.m.
Developing a menstrual-blood-based diagnostic for endometriosis, with Yana Aznavour, MD, PhD - Contemporary OB/GYN

Developing a menstrual-blood-based diagnostic for endometriosis, with Yana Aznavour, MD, PhD Contemporary OB/GYN

Published: May 22, 2026, 5:16 p.m.
Endometrial Serous Carcinoma Arising From Adenomyosis - Cureus

Endometrial Serous Carcinoma Arising From Adenomyosis Cureus

Published: May 22, 2026, 4:43 p.m.
5 Conditions Endometriosis Is Commonly Mistaken For—and Why Getting It Right Matters - AJMC

5 Conditions Endometriosis Is Commonly Mistaken For—and Why Getting It Right Matters AJMC

Published: May 22, 2026, 4:36 p.m.
Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer - Pharmacy Times

Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer Pharmacy Times

Published: May 22, 2026, 4:14 p.m.
I went to A&E four times before being diagnosed with endometriosis – I nearly died - MSN

I went to A&E four times before being diagnosed with endometriosis – I nearly died MSN

Published: May 22, 2026, 12:43 p.m.
Could the secret to diagnosing endometriosis be hiding in plain sight? - National Geographic

Could the secret to diagnosing endometriosis be hiding in plain sight? National Geographic

Published: May 22, 2026, 11:03 a.m.
Hinduja Hospital Launches Endometriosis Clinic in Mumbai - Voice of Healthcare

Hinduja Hospital Launches Endometriosis Clinic in Mumbai Voice of Healthcare

Published: May 22, 2026, 8:40 a.m.
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? - Pharmacy Times

Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? Pharmacy Times

Published: May 22, 2026, 4:29 a.m.
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 - OncLive

Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 OncLive

Published: May 22, 2026, 3:43 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!